Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-106.8%
operating margin TTM
-109.08%
revenue TTM
81.05 Million
revenue per share TTM
3.49$
valuation ratios | |
|---|---|
| pe ratio | -4.37 |
| peg ratio | -0.34 |
| price to book ratio | 2.47 |
| price to sales ratio | 5.07 |
| enterprise value multiple | -3.11 |
| price fair value | 2.47 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -109.08% |
| pretax profit margin | -108.62% |
| net profit margin | -106.8% |
| return on assets | -21.71% |
| return on equity | -78.59% |
| return on capital employed | -25.65% |
liquidity ratios | |
|---|---|
| current ratio | 4.44 |
| quick ratio | 4.44 |
| cash ratio | 0.84 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 46.28 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 46.28 |
| receivables turnover | 7.89 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.59 |
| debt equity ratio | 1.53 |
| long term debt to capitalization | 0.45 |
| total debt to capitalization | 0.60 |
| interest coverage | -8.30 |
| cash flow to debt ratio | -0.07 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.86 |
| cash per share | 8.69 |
| operating cash flow per share | -0.66 |
| free cash flow operating cash flow ratio | 1.30 |
| cash flow coverage ratios | -0.07 |
| short term coverage ratios | -0.44 |
| capital expenditure coverage ratio | -3.30 |
Frequently Asked Questions
When was the last time Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) reported earnings?
Enanta Pharmaceuticals, Inc. (ENTA) published its most recent earnings results on 11-02-2026.
What is Enanta Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)'s trailing twelve months ROE is -78.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Enanta Pharmaceuticals, Inc. (ENTA) currently has a ROA of -21.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ENTA's net profit margin stand at?
ENTA reported a profit margin of -106.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ENTA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.44 in the most recent quarter. The quick ratio stood at 4.44, with a Debt/Eq ratio of 1.53.